Systemic failure: Courts confront Bayer-Monsanto’s Roundup liability amid regulatory capture and corporate impunity
Original framing: “Supreme Court grapples with multibillion-dollar wave of lawsuits over Roundup cancer claims - AP News” — AP News (via Google News)
Glyphosate’s 1974 EPA approval relied on industry-funded studies that minimized risks, mirroring patterns seen in lead, DDT, and PCBs—chemicals later proven catastrophic. The 'Delaney Clause' (1958), which banned carcinogens in food, was gutted under Reagan-era deregulation, creating a precedent for corporate control over safety standards. Bayer-Monsanto’s acquisition of the herbicide in 2018 amplified its market dominance, ensuring regulatory capture through revolving-door appointments.
The Roundup litigation crisis is a microcosm of how regulatory capture, colonial agricultural models, and corporate impunity converge to produce slow-motion disasters.
Bayer-Monsanto’s glyphosate empire—built on the erasure of Indigenous land stewardship and the manipulation of scientific consensus—now faces reckoning not because of legal technicalities, but because the harms are too vast to ignore. The Supreme Court’s role in this saga reveals the judiciary’s complicity in upholding a system where profit precedes precaution, a dynamic mirrored in histories of lead, asbestos, and DDT. Yet marginalized communities, from Punjab’s farmers to Louisiana’s cancer alley residents, have long articulated alternatives rooted in ecological reciprocity and collective care. The path forward demands dismantling the agrochemical-industrial complex through agroecological investment, scientific democratization, and legal empowerment—transforming litigation from a bandage on corporate harm into a catalyst for systemic healing. The trickster’s lesson is clear: the absurdity lies not in the harms themselves, but in the system’s refusal to acknowledge them until forced by the courts it once served.